Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -21.98% |
| 2024 | -0.57% |
| 2023 | -5.76% |
| 2022 | 13.70% |
| 2021 | 154.65% |
| 2020 | 176.40% |
| 2019 | 62.70% |
| 2018 | 0.00% |